CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-1

The Basic Advocacy Training Session

The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.

  1. Medication Assisted Treatment  Basic clinical information about methadone and buprenorphine treatment.

  2. Regulations and Accreditation The federal regulations will be explained:  What they are and how they relate to the state regulations? Accreditation and what an accreditation survey is, how it is done, and how advocates can be involved.

  3. The Basics of Advocacy The different kinds of advocacy from “Hands On” Individual Advocacy (handling a grievavce), Networking, Systems Advocacy, Working with Policy Makers and Politicians.

  4. Stigma and Prejudice Patients themselves are often the greatest spreaders of stigma through ignorance and myths. Stigma will only end when society is educated about the effectiveness and benefits of MAT from the bottom up. We need to start with patients who can become ambassadors for MAT but this will be most effective with the support of policy makers and regulating agencies. The Media also spreads misinformation and stigma about MAT. Advocates need to have basic skills to work with the Media and write an Editorial, Letter to the Editor LTE and a Press Release.

  5. Advocate Certification What is certification and how it will professionalize those committed to MAT advocacy.  The Advocates Code of Ethics, the Goals of MAT Advocacy, and Advocate Certification.

Similar Posts

  • Exceptional Advocates

    Admin 12/02/2021

    The Board of Directors decided that the organization needed some mechanism to recognize NAMA chapters and other advocates who have done something that is exceptional. Thus it was decided that when their was an instance in which an advocate or individual took on a situation that was challenging and displayed exceptional skill in confronting it…

  • |

    Basic Information About Buprenorphine

    Admin 04/20/2023

    Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Summary of Title XXXV NIDA/SAMHSA Announcement & Press Release NIDA Research and…

  • Contact NAMA

    Admin 09/05/2021

    National Alliance for Medication Assisted Recovery (NAMA Recovery) 435 Second Avenue New York, NY 10010 Phone/Fax: (212) 595-NAMA/6262 For More Information Contact:    The President’s Office Directory of Affiliates and Chapters

  • Recertification

    Admin 04/06/2021

    Recertify for Your Medication Assisted Treatment Advocate (CMA) About Recertification We have had many persons who are certified contact us about recertification. Previously the only way to recertify was to take the training again. There have been some CMAs who saw their certification as so valuable that they have taken the training again. Steps to…